NEW YORK (AP) — U.S. pharmaceutical giant Pfizer signed a deal to purchase development-stage obesity drugmaker Metsera Inc., winning a bidding war against Novo Nordisk, the Danish drugmaker …
Tag:
obesity
Pfizer has won the bidding war against Novo Nordisk to acquire obesity-drug biotech Metsera. The pharma giant upped its offer, valuing the startup at up to around $10 …
- Sci/Health
Did Medicare price negotiations help Trump’s obesity drugs deals?
by eNewsBlogby eNewsBlogThe Trump administration’s deal on weight loss drugs might have been made possible in part by Biden’s Medicare drug price negotiation program, three experts said. Trump’s deal will …
Top of the morning to you, and a fine one it is. Despite howling winds lashing the Pharmalot campus, the skies are clear and sunny, and the official …
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — Novo Nordisk’s new CEO dismissed on Wednesday …
For years, obesity rates in the US have gone in one direction: up. From the first year it was launched, Gallup’s National Health and Well-Being Index has found …
